Gene Mack

Insider Reports History

Entity
Individual
Location
315 Madison Ave, New York, NY
Signature
/s/ Gene Mack
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gene Mack:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Gain Therapeutics, Inc. CFO and Interim CEO Common Stock 14.4K $14.5K $1.01 Aug 9, 2024 Direct
Gain Therapeutics, Inc. CFO and Interim CEO Employee Stock Option (right to buy) 200K Apr 8, 2024 Direct

Insider Reports Filed by Gene Mack

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GANX Gain Therapeutics, Inc. Aug 9, 2024 1 $14.5K 4 Aug 12, 2024 CFO and Interim CEO
GANX Gain Therapeutics, Inc. Apr 8, 2024 1 $0 4 Apr 8, 2024 Chief Financial Officer
GANX Gain Therapeutics, Inc. Apr 5, 2024 0 $0 3 Apr 8, 2024 Chief Financial Officer